Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-12

Clinical Trial Update: Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated liraglutide in combination with a sulfonylurea for blood glucose control in adults with type 2 diabetes; the study completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2010-03-12